Brakenhoff RH - Search Results

1

Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining.

de Boer DV, Brink A, Buijze M, Stigter-van Walsum M, Hunter KD, Ylstra B, Bloemena E, Leemans CR, Brakenhoff RH. de Boer DV, et al. Among authors: brakenhoff rh. Mol Cancer Res. 2019 Jan;17(1):120-130. doi: 10.1158/1541-7786.MCR-18-0445. Epub 2018 Sep 17. Mol Cancer Res. 2019. PMID: 30224542

2

Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform.

Van Hal NL, Van Dongen GA, Rood-Knippels EM, Van Der Valk P, Snow GB, Brakenhoff RH. Van Hal NL, et al. Among authors: brakenhoff rh. Int J Cancer. 1996 Nov 15;68(4):520-7. doi: 10.1002/(SICI)1097-0215(19961115)68:4<520::AID-IJC19>3.0.CO;2-8. Int J Cancer. 1996. PMID: 8945625 Free article.

3

Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines.

Braakhuis BJ, Klaassen I, van der Leede BM, Cloos J, Brakenhoff RH, Copper MP, Teerlink T, Hendriks HF, van der Saag PT, Snow GB. Braakhuis BJ, et al. Among authors: brakenhoff rh. Br J Cancer. 1997;76(2):189-97. doi: 10.1038/bjc.1997.361. Br J Cancer. 1997. PMID: 9231918 Free PMC article.

4

All-trans retinoic acid induced gene expression and growth inhibition in head and neck cancer cell lines.

Copper MP, Klaassen I, Brakenhoff RH, Cloos J, Snow GB, Braakhuis BJ. Copper MP, et al. Among authors: brakenhoff rh. Oral Oncol. 1997 Jul;33(4):270-4. doi: 10.1016/s0964-1955(97)00024-9. Oral Oncol. 1997. PMID: 9307717

5

Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.

van Gog FB, Brakenhoff RH, Stigter-van Walsum M, Snow GB, van Dongen GA. van Gog FB, et al. Among authors: brakenhoff rh. Int J Cancer. 1998 Jul 3;77(1):13-8. doi: 10.1002/(sici)1097-0215(19980703)77:1<13::aid-ijc3>3.0.co;2-2. Int J Cancer. 1998. PMID: 9639387 Free article.

6

Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction.

Brakenhoff RH, Stroomer JG, ten Brink C, de Bree R, Weima SM, Snow GB, van Dongen GA. Brakenhoff RH, et al. Clin Cancer Res. 1999 Apr;5(4):725-32. Clin Cancer Res. 1999. PMID: 10213205

7

Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.

van Hal NL, van Dongen GA, Stigter-van Walsum M, Snow GB, Brakenhoff RH. van Hal NL, et al. Among authors: brakenhoff rh. Int J Cancer. 1999 Sep 9;82(6):837-45. doi: 10.1002/(sici)1097-0215(19990909)82:6<837::aid-ijc12>3.0.co;2-h. Int J Cancer. 1999. PMID: 10446451 Free article.

8

Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.

Van Hal NL, Van Dongen GA, Ten Brink CB, Heider KH, Rech-Weichselbraun I, Snow GB, Brakenhoff RH. Van Hal NL, et al. Among authors: brakenhoff rh. Clin Cancer Res. 1999 Nov;5(11):3534-41. Clin Cancer Res. 1999. PMID: 10589769

9

Molecular diagnosis of head and neck cancer.

van Houten VM, van den Brekel MW, Denkers F, Colnot DR, Westerga J, van Diest PJ, Snow GB, Brakenhoff RH. van Houten VM, et al. Among authors: brakenhoff rh. Recent Results Cancer Res. 2000;157:90-106. doi: 10.1007/978-3-642-57151-0_8. Recent Results Cancer Res. 2000. PMID: 10857164 Review.

10

Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions.

van Houten VM, Tabor MP, van den Brekel MW, Denkers F, Wishaupt RG, Kummer JA, Snow GB, Brakenhoff RH. van Houten VM, et al. Among authors: brakenhoff rh. Clin Cancer Res. 2000 Oct;6(10):3803-16. Clin Cancer Res. 2000. PMID: 11051222 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

238 results

Search Page